Additionally, FSIP2 may play a role in metastasis, tumor invasion, and chemotherapeutic resistance and may be used as a predictive diagnostic biomarker for the prognosis of ccRCC. The gene discussed is FSIP2; the disease is nonpapillary renal cell carcinoma.